EE393 Cost Effectiveness Analysis of DTG/3TC Versus EVG/c/TAF/FTC and BIC/TAF/FTC for HIV-1 Infection Management in Treatment-Naïve Patients in China
Dec 1, 2022, 00:00
10.1016/j.jval.2022.09.639
https://www.valueinhealthjournal.com/article/S1098-3015(22)02843-1/fulltext
Title :
EE393 Cost Effectiveness Analysis of DTG/3TC Versus EVG/c/TAF/FTC and BIC/TAF/FTC for HIV-1 Infection Management in Treatment-Naïve Patients in China
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)02843-1&doi=10.1016/j.jval.2022.09.639
First page :
Section Title :
Open access? :
No
Section Order :
10173